IBDEI2UA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45291,1,3,0)
 ;;=3^Obesity, unspecified
 ;;^UTILITY(U,$J,358.3,45291,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,45291,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,45292,0)
 ;;=E74.39^^172^2262^25
 ;;^UTILITY(U,$J,358.3,45292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45292,1,3,0)
 ;;=3^Intestinal carbohydrate absorption disorder, other
 ;;^UTILITY(U,$J,358.3,45292,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,45292,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,45293,0)
 ;;=E78.1^^172^2262^17
 ;;^UTILITY(U,$J,358.3,45293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45293,1,3,0)
 ;;=3^Hyperglyceridemia, pure
 ;;^UTILITY(U,$J,358.3,45293,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,45293,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,45294,0)
 ;;=E78.5^^172^2262^20
 ;;^UTILITY(U,$J,358.3,45294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45294,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,45294,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,45294,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,45295,0)
 ;;=E86.0^^172^2262^13
 ;;^UTILITY(U,$J,358.3,45295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45295,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,45295,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,45295,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,45296,0)
 ;;=E87.1^^172^2262^21
 ;;^UTILITY(U,$J,358.3,45296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45296,1,3,0)
 ;;=3^Hypo-osmolality & hyponatremia
 ;;^UTILITY(U,$J,358.3,45296,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,45296,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,45297,0)
 ;;=E87.5^^172^2262^18
 ;;^UTILITY(U,$J,358.3,45297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45297,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,45297,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,45297,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,45298,0)
 ;;=E87.6^^172^2262^23
 ;;^UTILITY(U,$J,358.3,45298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45298,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,45298,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,45298,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,45299,0)
 ;;=E87.70^^172^2262^14
 ;;^UTILITY(U,$J,358.3,45299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45299,1,3,0)
 ;;=3^Fluid overload, unspecified
 ;;^UTILITY(U,$J,358.3,45299,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,45299,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,45300,0)
 ;;=E78.00^^172^2262^15
 ;;^UTILITY(U,$J,358.3,45300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45300,1,3,0)
 ;;=3^Hypercholesterolemia,Pure
 ;;^UTILITY(U,$J,358.3,45300,1,4,0)
 ;;=4^E78.00
 ;;^UTILITY(U,$J,358.3,45300,2)
 ;;=^5138435
 ;;^UTILITY(U,$J,358.3,45301,0)
 ;;=E78.49^^172^2262^19
 ;;^UTILITY(U,$J,358.3,45301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45301,1,3,0)
 ;;=3^Hyperlipidemia,Other
 ;;^UTILITY(U,$J,358.3,45301,1,4,0)
 ;;=4^E78.49
 ;;^UTILITY(U,$J,358.3,45301,2)
 ;;=^5157299
 ;;^UTILITY(U,$J,358.3,45302,0)
 ;;=F02.80^^172^2263^8
 ;;^UTILITY(U,$J,358.3,45302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45302,1,3,0)
 ;;=3^Dementia in oth diseases w/o behavrl disturb
 ;;^UTILITY(U,$J,358.3,45302,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,45302,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,45303,0)
 ;;=F02.81^^172^2263^7
 ;;^UTILITY(U,$J,358.3,45303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45303,1,3,0)
 ;;=3^Dementia in oth diseases w/ behavioral disturb
 ;;^UTILITY(U,$J,358.3,45303,1,4,0)
 ;;=4^F02.81
